Breaking News Instant updates and real-time market news.

IRTC

iRhythm

$84.16

1.02 (1.23%)

07:19
02/13/19
02/13
07:19
02/13/19
07:19

iRhythm price target raised to $109 from $96 at RBC Capital

RBC Capital analyst Glenn Novarro raised his price target on iRhythm to $109 and kept his Outperform rating after its Q4 revenue beat and better than expected outlook for FY19. The analyst notes that the company "handily beat" its initial guide last year and sees the guidance for this year as conservative as well. Novarro further expects the productivity of each sales rep to rise to $2.5M per year on average vs. prior forecast of $2.5M at its "peak".

IRTC iRhythm
$84.16

1.02 (1.23%)

09/13/18
ADAM
09/13/18
NO CHANGE
Target $100
ADAM
Buy
iRhythm weakness on Apple Watch an aggressive buying opportunity, says Canaccord
Canaccord analyst Jason Mills said he would be an aggressive buyer of iRhythm (IRTC) shares on weakness following the announcement of Apple's (AAPL)_next generation Watch Series 4. The analyst believes Apple's new watch will be a potential market expander of Zio, the iRhythm platform that is changing the paradigm in ambulatory ECG monitoring. He believes it could add another 3M tests to the TAM longer term. Mills reiterated his Buy rating and raised his price target to $100 from $93 on iRhythm shares.
09/13/18
JPMS
09/13/18
NO CHANGE
JPMS
Overweight
iRhythm selloff on Apple Watch a buying opportunity, says JPMorgan
JPMorgan analyst Robbie Marcus recommends investors use yesterday's weakness in shares of iRhythm Technologies (IRTC) as a buying opportunity. The stock sold off sharply after Apple (AAPL) announced that its new Watch Series 4 had received FDA approval for a built-in electrocardiogram scanner, Marcus tells investors in a research note. While the headline looks like a "notable headwind" for iRhythm, a closer look at the new device shows that this new feature poses almost no competitive threat to the company's Zio XT or AT offerings, Marcus contends. He does not see Apple turning the Watch into a regulated medical device approved for clinical diagnosis. The Apple Watch is approved for over-the-counter use and is not a continuous monitor, the analyst points out. Marcus believes Apple attaining an approval with a similar label to iRhythm's Zio "would significantly slow the rate of innovation and put the consumer device at the whim of the FDA." Instead, he expects that greater consumer preliminary screening for heart arrhythmias will only expand the number of patients seeking medical diagnosis, which, he feels, would benefit iRhythm. The analyst keeps an Overweight rating on the shares.
01/11/19
ADAM
01/11/19
NO CHANGE
Target $90
ADAM
Buy
iRhythm price target raised to $90 from $84 at Canaccord
Canaccord analyst Jason Mills raised his price target on iRhythm to $90 from $84 and said it represents one of his top picks for 2019. The analyst believes the company will maintain strong growth and its large competitive moat. He expects improving gross margins, thinks the scaling of its U.S. salesforce should translate to revenue upside, and projects increased market share gains. Mills reiterated his Buy rating on iRhythm shares.
02/13/19
JPMS
02/13/19
NO CHANGE
Target $110
JPMS
Overweight
iRhythm price target raised to $110 from $100 at JPMorgan
JPMorgan analyst Robbie Marcus raised his price target for iRhythm to $110 saying the company posted an "impressive" close to the year with accelerating Q4 growth and better than expected 2019 guidance. The analyst reiterates iRhythm as his top SMID-cap pick.

TODAY'S FREE FLY STORIES

MESO

Mesoblast

$4.28

0.13 (3.13%)

17:26
02/20/19
02/20
17:26
02/20/19
17:26
Earnings
Mesoblast reports 1H19 $44.1M loss versus 1H18 profit of $6.7M »

In the first half FY2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

KODK

Kodak

$3.03

-0.045 (-1.47%)

17:21
02/20/19
02/20
17:21
02/20/19
17:21
Hot Stocks
Kodak names Jim Continenza executive chairman »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:20
02/20/19
02/20
17:20
02/20/19
17:20
Hot Stocks
Macquarie Infrastructure sees FY19 EBITDA $610M-$635M vs. $601.9M last year »

Sees FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:19
02/20/19
02/20
17:19
02/20/19
17:19
Earnings
Macquarie Infrastructure reports Q4 adj. EBITDA $152.4M vs. $159.6M last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Hot Stocks
Breaking Hot Stocks news story on Cheesecake Factory »

Cheesecake Factory sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Earnings
Cheesecake Factory sees Q1 adjusted EPS 58c-62c, consensus 61c »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

HTBK

Heritage Commerce

$14.17

0.17 (1.21%)

17:15
02/20/19
02/20
17:15
02/20/19
17:15
Hot Stocks
Heritage Commerce director Robert Moles sells almost 50K shares »

Heritage Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVI

CVR Energy

$42.99

0.325 (0.76%)

17:12
02/20/19
02/20
17:12
02/20/19
17:12
Earnings
CVR Energy reports Q4 EPS 82c, consensus 98c »

Reports Q4 revenue $1.7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

VMI

Valmont

$139.23

1.56 (1.13%)

17:09
02/20/19
02/20
17:09
02/20/19
17:09
Hot Stocks
Valmont, Prospera Technologies announce partnership »

Valmont Industries and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RGR

Sturm, Ruger

$59.60

0.505 (0.85%)

17:08
02/20/19
02/20
17:08
02/20/19
17:08
Hot Stocks
Sturm, Ruger declares Q4 dividend of 28c per share vs. 21c in Q3 »

The dividend for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RGR

Sturm, Ruger

$59.60

0.505 (0.85%)

17:06
02/20/19
02/20
17:06
02/20/19
17:06
Earnings
Sturm, Ruger reports Q4 adjusted EPS 69c, one estimate 79c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SM

SM Energy

$19.70

0.61 (3.20%)

17:05
02/20/19
02/20
17:05
02/20/19
17:05
Hot Stocks
SM Energy sees FY19 total production 45-48 MMBoe »

Sees FY19 lease operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KREF

KKR Real Estate Finance

$20.21

-0.1 (-0.49%)

17:05
02/20/19
02/20
17:05
02/20/19
17:05
Earnings
KKR Real Estate Finance reports Q4 core EPS 38c, consensus 41c »

Book value was $19.66 per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 04

    Jun

SM

SM Energy

$19.70

0.61 (3.20%)

17:04
02/20/19
02/20
17:04
02/20/19
17:04
Earnings
SM Energy sees Q1 total production 10.5-10.9 MMBoe »

Sees Q1 total capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SM

SM Energy

$19.70

0.61 (3.20%)

17:04
02/20/19
02/20
17:04
02/20/19
17:04
Earnings
SM Energy reports Q4 adjusted EPS (18c), consensus (14c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

VVV

Valvoline

$19.86

0.52 (2.69%)

17:04
02/20/19
02/20
17:04
02/20/19
17:04
Hot Stocks
Valvoline enters quick lube joint venture in China with The Master Too »

Valvoline announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNKD

MannKind

$1.47

-0.02 (-1.34%)

17:03
02/20/19
02/20
17:03
02/20/19
17:03
Hot Stocks
MannKind to present new positive Afrezza clinical data at ATTD »

MannKind announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

LYFT

Lyft

$0.00

(0.00%)

, UBER

Uber

$0.00

(0.00%)

17:03
02/20/19
02/20
17:03
02/20/19
17:03
Periodicals
Lyft plans roadshow for IPO week of March 18, Reuters says »

Lyft (LYFT) plans to…

LYFT

Lyft

$0.00

(0.00%)

UBER

Uber

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMCF

Emclaire Financial

$30.12

-0.88 (-2.84%)

17:03
02/20/19
02/20
17:03
02/20/19
17:03
Hot Stocks
Emclaire Financial increases quarterly dividend 3.6% »

The board of Emclaire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

ATR

AptarGroup

$102.12

0.69 (0.68%)

17:01
02/20/19
02/20
17:01
02/20/19
17:01
Earnings
Breaking Earnings news story on AptarGroup »

Aptar sees Q1 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    May

CBFV

CB Financial Services

$26.22

0.6 (2.34%)

17:01
02/20/19
02/20
17:01
02/20/19
17:01
Hot Stocks
CB Financial Services raises quarterly dividend 4.3% to 24c from 23c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$107.90

-1.37 (-1.25%)

17:01
02/20/19
02/20
17:01
02/20/19
17:01
Earnings
Equifax sees FY19 EPS $5.60-$5.80, consensus $5.86 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ATR

AptarGroup

$102.12

0.69 (0.68%)

17:01
02/20/19
02/20
17:01
02/20/19
17:01
Earnings
Aptar reports Q4 adjusted EPS 92c, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    May

EFX

Equifax

$107.90

-1.37 (-1.25%)

17:00
02/20/19
02/20
17:00
02/20/19
17:00
Earnings
Equifax sees Q1 EPS $1.15-$1.20, consensus $1.39 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EFX

Equifax

$107.90

-1.37 (-1.25%)

16:59
02/20/19
02/20
16:59
02/20/19
16:59
Earnings
Equifax reports Q4 adjusted EPS $1.38, consensus $1.32 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.